3,022 Astera Labs, Inc. $ALAB Shares Acquired by Ilmarinen Mutual Pension Insurance Co

Ilmarinen Mutual Pension Insurance Co grew its position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 18.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,532 shares of the company’s stock after buying an additional 3,022 shares during the quarter. Ilmarinen Mutual Pension Insurance Co’s holdings in Astera Labs were worth $6,953,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Keating Financial Advisory Services Inc. bought a new stake in shares of Astera Labs in the second quarter worth $25,000. Archer Investment Corp purchased a new stake in Astera Labs during the second quarter valued at $30,000. Transamerica Financial Advisors LLC bought a new position in Astera Labs in the second quarter valued at about $35,000. Continuum Advisory LLC bought a new position in Astera Labs in the second quarter valued at about $37,000. Finally, GK Wealth Management LLC bought a new position in Astera Labs in the third quarter valued at about $29,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, General Counsel Philip Mazzara sold 4,380 shares of Astera Labs stock in a transaction dated Monday, November 16th. The stock was sold at an average price of $206.62, for a total transaction of $904,995.60. Following the transaction, the general counsel directly owned 92,190 shares of the company’s stock, valued at $19,048,297.80. The trade was a 4.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 96,089 shares of the business’s stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $206.62, for a total value of $19,853,909.18. Following the transaction, the chief operating officer owned 1,022,949 shares of the company’s stock, valued at approximately $211,361,722.38. This trade represents a 8.59% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 417,090 shares of company stock valued at $102,663,347. 10.40% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on ALAB. Weiss Ratings cut Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research report on Friday, October 23rd. Morgan Stanley upped their price target on shares of Astera Labs from $382.00 to $389.00 and gave the company an “overweight” rating in a research report on Wednesday, November 4th. BMO Capital Markets initiated coverage on shares of Astera Labs in a research note on Thursday, November 5th. They issued an “outperform” rating and a $375.00 price objective on the stock. Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Finally, Citigroup downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Friday, October 9th. Twelve research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and a consensus target price of $325.89.

View Our Latest Stock Analysis on ALAB

Astera Labs Price Performance

Shares of ALAB stock opened at $179.58 on Friday. The company has a market cap of $31.39 billion, a price-to-earnings ratio of 71.55 and a beta of 3.85. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The firm has a fifty day moving average price of $285.19 and a 200-day moving average price of $258.24.

Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.13. The company had revenue of $584.90 million for the quarter, compared to analysts’ expectations of $550.78 million. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. Astera Labs’s revenue for the quarter was up 153.6% compared to the same quarter last year. During the same period last year, the firm earned $0.49 EPS. Equities research analysts expect that Astera Labs, Inc. will post 2.99 EPS for the current year.

About Astera Labs

(Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

See Also

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.